Patents by Inventor Douglas R. Pfeiffer

Douglas R. Pfeiffer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20020090619
    Abstract: The invention relates to methods for identifying nucleic acid molecules that encode mitochondrial divalent cation transporter polypeptides, which in preferred embodiments are mitochondrial calcium uniporters. Preferred methods employ host cells for expression screening of nucleic acid libraries encoding candidate cation transporters, where the host cells comprise a mitochondrially targeted divalent cation-sensitive indicator molecule. In certain preferred embodiments host cells comprise a mitochondrially targeted esterase that is capable of cleaving a divalent cation sensitive indicator molecule precursor to provide a divalent cation sensitive indicator molecule, or an expression construct directing the expression of such esterase. Host cells that lack endogenous calcium uniporter activity, or that exhibit impaired cell growth in the presence of cytostatic Ca2+ concentrations, are also described.
    Type: Application
    Filed: June 29, 2001
    Publication date: July 11, 2002
    Inventors: Douglas R. Pfeiffer, Anne N. Murphy, Dennis W. Jung, Patrick C. Bradshaw
  • Patent number: 4959357
    Abstract: Potent, specific inhibitors of phospholipase A.sub.2 are disclosed which are compounds of the formula: ##STR1## wherein A is R.sub.1 CO.sub.2 or OH, B is R.sub.2 CO.sub.2 or OH, D is R.sub.3 CO.sub.2 or OH and C is R.sub.4 CO.sub.2 ; and wherein R.sub.1, R.sub.2, and R.sub.3 and R.sub.4 are each C.sub.10 -C.sub.30 alkyl groups comprising from about 0-3 double bonds.
    Type: Grant
    Filed: August 23, 1985
    Date of Patent: September 25, 1990
    Assignee: Regents of the University of Minnesota
    Inventors: Martin Reers, Douglas R. Pfeiffer
  • Patent number: 4227002
    Abstract: Halo-A-23187 derivatives, prepared by reaction of antibiotic A-23187 with an N-halo-type halogenating agent, and salts thereof, which are (1) useful biochemical tools for the study of transport of ions in cellular systems, (2) useful chemical tools for removal and recovery of ions, and (3) potential cardiotonic agents.
    Type: Grant
    Filed: October 11, 1978
    Date of Patent: October 7, 1980
    Assignee: Eli Lilly and Company
    Inventors: Donner F. Babcock, Charles M. Deber, Manuel Debono, R. Michael Molloy, Douglas R. Pfeiffer